Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Sirtuin 1 (SIRT1) is a nuclear deacetylase that modulates lipid metabolism and enhances mitochondrial activity. SIRT1 targets multiple transcription factors and coactivators. Thyroid hormone (T 3 ) stimulates the expression of hepatic genes involved in mitochondrial fatty acid oxidation and gluconeogenesis. We reported that T 3 induces genes for carnitine palmitoyltransferase ( cpt1a ), pyruvate dehydrogenase kinase 4 ( pdk4 ), and phosphoenolpyruvate carboxykinase ( pepck ). SIRT1 increases the expression of these genes via the activation of several factors, including peroxisome proliferator-activated receptor α, estrogen-related receptor α, and peroxisome proliferator-activated receptor γ coactivator (PGC-1α). Previously, we reported that PGC-1α participates in the T 3 induction of cpt1a and pdk4 in the liver. Given the overlapping targets of T 3 and SIRT1, we investigated whether SIRT1 participated in the T 3 regulation of these genes. Resveratrol is a small phenolic compound whose actions include the activation of SIRT1. Addition of resveratrol increased the T 3 induction of the pdk4 and cpt1a genes in hepatocytes. Furthermore, expression of SIRT1 in hepatocytes mimicked resveratrol in the regulation of gene expression by T 3 . The deacetylase activity of SIRT1 was required and PGC-1α was deacetylated following addition of T 3 . We found that SIRT1 interacted directly with T 3 receptor (TRβ). Knockdown of SIRT1 decreased the T 3 induction of cpt1a and pdk4 and reduced the T 3 inhibition of sterol response element binding protein ( srebp-1c ) both in isolated hepatocytes and in rat liver. Our results indicate that SIRT1 contributes to the T 3 regulation of hepatic genes. Background: Sirtuin 1 elevates the expression of genes involved in hepatic fatty acid oxidation. Results: Sirtuin 1 modulates the thyroid hormone regulation of the cpt1a , pdk4 , and srebp-1c genes. Conclusion: Sirtuin 1 coregulates the thyroid hormone receptor-mediated induction of gene expression. Significance: Activators of sirtuin 1 and thyroid hormone receptor β agonists could cooperatively stimulate fatty acid oxidation and inhibit lipogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160 · cited 6×
“SIRT1 activates PGC-1 by deacetylation (19).”
BackgroundMethodInfluentialMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 6×
“SIRT1 directly interacts with and activates ERR (24).”
BackgroundInfluentialPhysiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011 · cited 1×
“The two isoforms ofTR includeTR and TR , which is the isoform most highly expressed in the liver (4).”
BackgroundSmall molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · cited 2×
“Resveratrol also has positive hepatic actions including the enhancement of mitochondrial metabolism and the reduction of hepatic steatosis (55).”
BackgroundMethodThe Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 1×
“CPT1a catalyzes the translocation of long chain acyl-CoA to acyl-carnitine and is an initiating step in mitochondrial fatty acid oxidation (10).”
BackgroundMolecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
Gerhart‐Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S., Mostoslavsky, R., Alt, F. W., Wu, Z., & Puigserver, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601633 · Cited by 1,294 · cited 1×
“Chromatin Immunoprecipitation Assay—The ChIP assays were done according to the protocol provided with Millipore magnaChIP kit (17-610).”
MethodLeone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915 · cited 4×
“Resveratrol activates AMPK and some of the actions of resveratrol on the T3 induction could bemediated by AMPK (52).”
BackgroundMethodInfluentialFeige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719 · cited 2×
“Activation of SIRT1 by administration of resveratrol improved mitochondrial function, increased fatty acid oxidation, and decreased lipogenesis (17, 28, 29).”
BackgroundMethod
Cited by
Direct effects of thyroid hormones on hepatic lipid metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.10 · Cited by 660
Sinha, R. A., Bruinstroop, E., Singh, B. K., & Yen, P. M. (2019) · Thyroid · doi:10.1089/thy.2018.0664 · Cited by 271
Molecular Mechanisms and Signaling Pathways Involved in Sertoli Cell Proliferation
Meroni, S. B., Galardo, M. N., Rindone, G., Gorga, A., Riera, M. F., & Cigorraga, S. B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00224 · Cited by 229
Thyroid hormone signaling and the liver
Ritter, M. J., Amano, I., Hollenberg, A. N., et al. (2020) · Hepatology · doi:10.1002/hep.31296 · Cited by 188
“(66) Indirectly, TH acts through sirtuin 1 and PPARα to increase levels of Cpt1.”
BackgroundNovel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160
Singh, B. K., Sinha, R. A., Tripathi, M., Mendoza, A., Ohba, K., Sy, J. A. C., Xie, S. Y., Zhou, J., Ho, J. P., Chang, C.-Y., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aam5855 · Cited by 145
Metadata
- Authors
- Thakran, S., Sharma, P., Attia, R. R., Hori, R. T., Deng, X., Elam, M. B., & Park, E. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 288
- Issue
- 2
- Pages
- 807-818
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2026168844
- Cited by
- 84
- References
- 14
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.